Viewing Study NCT01628094


Ignite Creation Date: 2025-12-25 @ 1:32 AM
Ignite Modification Date: 2025-12-31 @ 4:08 PM
Study NCT ID: NCT01628094
Status: COMPLETED
Last Update Posted: 2016-11-02
First Post: 2012-06-22
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: ANNAPURNA: A Study of The Combination of RO5466731, RO5190591, Ritonavir and Copegus (Ribavirin) With or Without RO5024048 in Patients With Chronic Hepatitis C Who Are Either Treatment-Naïve or Have Previously Experienced a Null Response to Interferon-Based Treatment
Sponsor: Hoffmann-La Roche
Organization:

Key Dates - Follows AllAPIJSON File Order

Start Date: 2012-06
Start Date Type: None
Primary Completion Date: 2013-11
Primary Completion Date Type: ACTUAL
Completion Date: 2013-11
Completion Date Type: ACTUAL
First Submit Date: 2012-06-22
First Submit QC Date: None
Study First Post Date: 2012-06-26
Study First Post Date Type: ESTIMATED
Results First Submit Date: None
Results First Submit QC Date: None
Results First Post Date: None
Results First Post Date Type: None
Results First Post QC Date: None
Results First Post QC Date Type: None
Disp First Submit Date: None
Disp First Submit QC Date: None
Disp First Post Date: 2016-07-04
Disp First Post Date Type: ESTIMATED
Last Update Submit Date: 2016-11-01
Last Update Post Date: 2016-11-02
Last Update Post Date Type: ESTIMATED